Palo Alto, CANCT06033924Now EnrollingIRB Ready

Peripheral Artery Disease Clinical Trial in Palo Alto, CA

Access cutting-edge peripheral artery disease treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.

Sponsored by VA Office of Research and Development

Quick Self-Assessment

See if you qualify for this Palo Alto location

Preparing your pre-screening questions…

Expert Care in Palo Alto

Access peripheral artery disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related peripheral artery disease treatment provided free

Apply for This Palo Alto Location

Check if you qualify for this peripheral artery disease clinical trial in Palo Alto, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Palo Alto

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Palo Alto site if eligible
  4. 4Begin participation

About This Peripheral Artery Disease Study in Palo Alto

Walking is beneficial for adults with peripheral arterial disease. Benefits include the ability to walk for longer periods and general well being (quality of life). This study will look at two types of delivery methods for a home-based walking program. The walking program includes step count goals, information on healthy walking and motivational messages. The two delivery methods include a web-based delivery and an telehealth delivery. Participants are randomized to either one of the delivery methods or usual care. After 12 weeks participants in the web based or telehealth based groups maybe re-randomized to receive a combination of both web-based and telehealth for a second 12 week period. After 24 weeks, everyone is followed for an additional 12 weeks, so the total time a participant is in the study is 36 weeks. At baseline, 12, 24 and 36 weeks the investigators ask participant to walk (slowly) on a treadmill, perform a six-minute walk test, and several questionnaires on quality of life. Vouchers are provided at each study visit. All participants who complete the study also keep their pedometer.

Sponsor: VA Office of Research and Development

Who Can Participate

Inclusion Criteria

Men and women
Diagnosis of lower extremity PAD due to atherosclerosis
Claudication with walking defined as stage 1-3 on the Rutherford Scale
Medical clearance from the patient's primary care provider or vascular care provider
Ability to walk at least one city block
Self-reported sedentary behaviors defined as \< 150 minutes per week of physical activity
Access to a phone and/or email \& Internet
Competent to provide informed consent

Exclusion Criteria

Life expectancy of less than six months
Comorbidities that limit walking to a severe degree (i.e., wheelchair-bound)
Resident of a nursing home
Recent enrollment in an exercise program or performing 150 minutes per week or more of exercise
Planned revascularization or amputation in the next two months
Recent CVD events (\< 3 months) including stroke/TIA, MI, UA, PCI/CABG
Unstable cardiac conditions (severe valve disease, NYHA class III-IV heart failure, untreated complex congenital heart disease, or complex arrhythmias)
Current substance abuse
Psychiatric disorder which limits the patient's ability to follow the study protocol
Inability to speak and read English

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Palo Alto?

Yes, this clinical trial (NCT06033924) has an active research site in Palo Alto, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Peripheral Artery Disease Treatment Options in Palo Alto, CA

If you're searching for peripheral artery disease treatment options in Palo Alto, CA, this clinical trial (NCT06033924) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced peripheral artery disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all peripheral artery disease clinical trials near you to find additional studies recruiting in your area.

More Peripheral Artery Disease Trials in Palo Alto, CA

See all peripheral artery disease clinical trials recruiting in Palo Alto — not just this study.

Browse Peripheral Artery Disease Trials in Palo Alto

Ready to Join in Palo Alto?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Palo Alto, CA